澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Opthea Ltd

0.390

0.000

成交量：- -

成交额：- -

市值：- -

市盈率：- -

高：0.390

开：0.390

低：0.390

收：0.390

52周最高：0.580

52周最低：0.210

股本：- -

流通股本：- -

量比：- -

换手率：- -

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Opthea Ltd

交易所：

ASX

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.opthea.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Opthea Limited于1984年根据澳大利亚法律注册成立，名称为Circadian Technologies Limited。该公司是一家临床阶段生物制药公司，致力于开发一种新型疗法，用于治疗高度流行和进行性视网膜疾病。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/OPTOA.AU/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OPTOA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OPTOA.AU\",,,,,undefined,":{"symbol":"OPTOA.AU","market":"AU","secType":"STK","nameCN":"Opthea Ltd","latestPrice":0.39,"timestamp":1766034000000,"preClose":0.39,"halted":0,"volume":0,"delay":0,"nameEN":"Opthea Ltd","floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":0,"latestTime":"12-18 16:00:00 AEDT","open":0.39,"high":0.39,"low":0.39,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1766098800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.39,"openAndCloseTimeList":[[1766012400000,1766034000000]],"volumeRatio":0,"lotSize":0,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OPTOA.AU\",,,,,undefined,":{"symbol":"OPTOA.AU","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0.39,"amplitude":0,"preClose":0.39,"low":0.39,"week52Low":0.21,"pbRate":"--","week52High":0.58,"institutionHeld":0,"latestPrice":0.39,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0.39,"prevYearClose":0.3,"prevWeekClose":0.39,"prevMonthClose":0.39,"prevQuarterClose":0.39,"fiveDayClose":0.39,"twentyDayClose":0.39,"sixtyDayClose":0.39},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OPTOA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OPTOA.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.opthea.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0.8571},{"period":"ytd","weight":0.3}],"compareEarnings":[{"period":"1week","weight":0.0197},{"period":"1month","weight":0.0211},{"period":"3month","weight":0.049},{"period":"6month","weight":0.0914},{"period":"1year","weight":0.239},{"period":"ytd","weight":0.246}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Opthea Limited于1984年根据澳大利亚法律注册成立，名称为Circadian Technologies Limited。该公司是一家临床阶段生物制药公司，致力于开发一种新型疗法，用于治疗高度流行和进行性视网膜疾病。","exchange":"ASX","name":"Opthea Ltd","nameEN":"Opthea Ltd"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"OPTOA.AU\",market:\"AU\",,,undefined,":null}}